BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19149502)

  • 1. Recent advances in obesity pharmacotherapy.
    Mayer MA; Höcht C; Puyó A; Taira CA
    Curr Clin Pharmacol; 2009 Jan; 4(1):53-61. PubMed ID: 19149502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant.
    Rubio MA; Gargallo M; Isabel Millán A; Moreno B
    Public Health Nutr; 2007 Oct; 10(10A):1200-5. PubMed ID: 17903331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk.
    Caterson ID; Finer N
    Asia Pac J Clin Nutr; 2006; 15 Suppl():55-62. PubMed ID: 16928662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacotherapy for obesity: current drugs and those in advanced development.
    Halford JC
    Curr Drug Targets; 2004 Oct; 5(7):637-46. PubMed ID: 15473253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy in the treatment of obesity].
    Hamann A
    MMW Fortschr Med; 2006 Mar; 148(9):36-8. PubMed ID: 16566392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatments for obesity: orlistat, sibutramine, and rimonabant.
    Padwal RS; Majumdar SR
    Lancet; 2007 Jan; 369(9555):71-7. PubMed ID: 17208644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for obesity.
    Neff LM; Aronne LJ
    Curr Atheroscler Rep; 2007 Dec; 9(6):454-62. PubMed ID: 18377785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug treatment of obesity].
    Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
    Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatment for obesity. Options for today...and tomorrow.
    Lundquist LM; Sirimaturos M; Cannon E
    Adv Nurse Pract; 2006 Aug; 14(8):31-5, 64. PubMed ID: 16972485
    [No Abstract]   [Full Text] [Related]  

  • 11. A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity.
    Gray LJ; Cooper N; Dunkley A; Warren FC; Ara R; Abrams K; Davies MJ; Khunti K; Sutton A
    Obes Rev; 2012 Jun; 13(6):483-98. PubMed ID: 22288431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis.
    Johansson K; Neovius K; DeSantis SM; Rössner S; Neovius M
    Obes Rev; 2009 Sep; 10(5):564-75. PubMed ID: 19460116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for obesity.
    Li M; Cheung BM
    Br J Clin Pharmacol; 2009 Dec; 68(6):804-10. PubMed ID: 20002075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid system as a target for obesity treatment.
    Aronne LJ; Pagotto U; Foster GD; Davis SN
    Clin Cornerstone; 2008; 9(1):52-64; discussion 65-6. PubMed ID: 19046740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacotherapy of obesity].
    Hamann A
    Internist (Berl); 2008 Jan; 49(1):106-13. PubMed ID: 18060334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight management and current options in pharmacotherapy: orlistat and sibutramine.
    Leung WY; Thomas GN; Chan JC; Tomlinson B
    Clin Ther; 2003 Jan; 25(1):58-80. PubMed ID: 12637112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy of obesity].
    Rotthoff T; Scherbaum WA
    Med Monatsschr Pharm; 2006 Dec; 29(12):433-8; quiz 439-40. PubMed ID: 17220037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and cardiovascular physiology: impact of some pharmacological agents.
    Chaput JP; Bérubé-Parent S; Tremblay A
    Curr Vasc Pharmacol; 2005 Apr; 3(2):185-93. PubMed ID: 15853638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiobesity medications in patients with type 2 diabetes mellitus.
    Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS
    Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy to reduce visceral fat.
    Blackburn GL; Waltman BA
    Clin Cornerstone; 2005; 7(2-3):52-60. PubMed ID: 16473261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.